Yuki Gosei Kogyo Co., Ltd.

Tokyo Stock Exchange 4531.T

Yuki Gosei Kogyo Co., Ltd. Market Capitalization on January 31, 2025: USD 36.50 M

Yuki Gosei Kogyo Co., Ltd. Market Capitalization is USD 36.50 M on January 31, 2025, a -12.47% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.
  • Yuki Gosei Kogyo Co., Ltd. 52-week high Market Capitalization is USD 48.92 M on February 27, 2024, which is 34.02% above the current Market Capitalization.
  • Yuki Gosei Kogyo Co., Ltd. 52-week low Market Capitalization is USD 35.44 M on December 26, 2024, which is -2.92% below the current Market Capitalization.
  • Yuki Gosei Kogyo Co., Ltd. average Market Capitalization for the last 52 weeks is USD 40.80 M.
Key data
Date Market Capitalization Share Price Price to Earnings Ratio (P/E) Price to Sales Ratio (P/S)
Market news
SV Wall Street
Tokyo Stock Exchange: 4531.T

Yuki Gosei Kogyo Co., Ltd.

CEO Seiichiro Matsumoto
IPO Date Jan. 4, 2001
Location Japan
Headquarters 10-4, Nihonbashi-Ningyocho 3-chome
Employees 290
Sector Health Care
Industries
Pharmaceuticals Chemicals & Advanced Materials Petrochemicals
Description

Yuki Gosei Kogyo Co., Ltd. researches, develops, manufactures, and markets fine chemical products in Japan and internationally. It offers food additives, pharmaceuticals, and industrial and agricultural chemicals; and glycine, glycine compounds, nicotinic acid amide, isoniazid, drug intermediates, and cosmetic ingredients. The company also provides amino acid, pyridine, piperidine, silicon, and other compounds; DNA, nucleoside, and protamine; and active pharmaceutical ingredients. In addition, it engages in the contract manufacturing of pharmaceuticals and chemical products. Yuki Gosei Kogyo Co., Ltd. was founded in 1947 and is headquartered in Tokyo, Japan.

StockViz Staff

February 1, 2025

Any question? Send us an email